ArticleCell communication and signaling : CCS2026
FAK signaling pathways are modulated by HSPB8 and BAG3 in breast cancer.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
Abstract
backgroundBreast cancer (BC) is a widespread and heterogeneous disease in which autophagy plays an essential role in tumor development and progression. It has been suggested that autophagy activation may prevent tumor development in the initial stages of the disease, while in more advanced stages, autophagy might activate survival mechanisms for cancer cells. Moreover, autophagy may be involved in developing therapies resistance and in forming metastases. Some Heat Shock Proteins (HSPs) play an important role in autophagy. The small HSPB8 draws attention because it is generally highly expressed in Estrogen Receptor positive (ER+) BC and its over-expression increases autophagic flux, proliferation, migration and survival of BC cells under stress conditions. HSPB8 mediates the autophagic degradation of client proteins via the chaperone-assisted selective autophagy (CASA) complex in which it binds the BAG cochaperone 3 (BAG3), the HSP70 and the E3-ubiquitin ligase STUB1. Similarly to HSPB8, BAG3 is also highly expressed in BC cells, and its unregulated expression is linked to a poor prognosis. In our previous studies, we showed that HSPB8 and BAG3 silencing reduces proliferation and migratory capacities of hormone-sensitive MCF-7 BC cells.
methodsHere, we analyzed the signal transduction mechanisms involved in HSPB8- and BAG3-mediated regulation of metastatic potential. We evaluated the function of protein tyrosine kinase 2 (PTK2 also known as FAK), known to activate several downstream signals controlling PI3K, AKT and MAP kinases.
resultsWe demonstrated that HSPB8 and BAG3 downregulation correlated with a significant reduction in the phosphorylated and active form of FAK which, in a cascade mechanism, induces a decrease in the proliferative, migratory, and adhesive capacity of MCF-7 and T47D ER+ human BC cell lines. Furthermore, co-immunoprecipitation studies demonstrated a co-localization between BAG3 and FAK, also confirmed by Immunofluorescence staining in BC specimen sections.
conclusionBased on our results, we suggest that BAG3 associates with FAK and, together with HSPB8, modulates the signal transduction mechanisms controlling the survival of the hormone-sensitive human ER+, PR positive (PR+), HER2 negative (HER2−) BC cell lines MCF-7 and T47D.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.